Tapan K. Nayak

Bulk properties of the medium produced in relativistic heavy-ion collisions from the beam energy scan program

L. Adamczyk, J. K. Adkins, G. Agakishiev et al. · Physical review. C · 2017 · 621 citations · Full text

Natural Sciences, Physics, Chemical Kinetics +15

In vivo effects of a GPR30 antagonist

Megan K. Dennis, Ritwik Burai, Chinnasamy Ramesh et al. · Nature Chemical Biology · 2009 · 521 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +6

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 283 citations · Full text

Life Sciences, Immunology, Oncology +17

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

C. Willemien Menke‐van der Houven van Oordt, Carlos Gomez-Roca, Carla van Herpen et al. · Oncotarget · 2016 · 156 citations · Full text

Medicine, Cancer Biology, Oncology +14

Observation of Charge Asymmetry Dependence of Pion Elliptic Flow and the Possible Chiral Magnetic Wave in Heavy-Ion Collisions

L. Adamczyk, J. K. Adkins, G. Agakishiev et al. · Physical Review Letters · 2015 · 127 citations · Full text

Natural Sciences, Physics, Electromagnetism +6